Cirrhosis/Liver Failure News

April is Alcohol Awareness Month, an annual campaign originally created to raise awareness about alcoholism and the impacts of alcohol on health — and a month-long opportunity to open a dialogue on the topic with patients.

The prevalence of nonalcoholic fatty liver disease was 14% among pregnant women screened during early pregnancy, with fewer than 5% receiving prior evaluation for NAFLD, according to research in Clinical Gastroenterology and Hepatology.

A machine learning model using artificial neural networks demonstrated “superior performance” compared with MELD score for predicting 28-day mortality among patients with hepatic encephalopathy, according to data in BMC Gastroenterology.

Results from a systematic review and meta-analysis demonstrated greater risk for hepatitis C virus and HIV infection among women and younger people who inject drugs, according to data reported in The Lancet Gastroenterology & Hepatology.

Although semaglutide did not “significantly improve” fibrosis in patients with nonalcoholic steatohepatitis and compensated cirrhosis, notable improvements were reported in cardiometabolic parameters and markers of liver fat and injury.

A 2011 FDA mandate, which limited acetaminophen dosage to 325 mg/tablet in prescription acetaminophen and opioid products, correlated with a decrease in yearly hospitalizations and cases of acute liver failure related to toxicity.

Hepatic steatosis may be present in most adults with type 1 diabetes, especially those with overweight or obesity, according to a study published in Journal of Diabetes and Its Complications.

Physically active patients with nonalcoholic fatty liver disease were more likely to achieve at least a 30% reduction in MRI-measured liver fat, according to research in The American Journal of Gastroenterology.

Antibiotic prophylaxis failed to reduce the incidence of hospital-acquired infections or overall mortality among patients with decompensated cirrhosis, according to data published in The American Journal of Gastroenterology.

Consuming at least 20% of daily calories from fast food correlated with an increased risk for nonalcoholic fatty liver disease, with more damaging effects among individuals with underlying metabolic comorbidities.